相关实验视频

Updated: May 6, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.0K

EXOSC5:一个新的生物标志物,用于肺腺癌的不良预后

Jianxun Xu1, Zhengwei Zhang1, Keyao Han1

  • 1Affiliated Hospital of Nantong University, Nantong, China.

BMC cancer
|April 14, 2025
PubMed
概括

外体组复合基因5 (EXOSC5) 驱动肺腺癌 (LUAD) 的进展和免疫逃避. 在LUAD患者中,EXOSC5的升调预测了不良预后和抗PD1免疫疗法的耐药性.

关键词:
抗PD1疗法是一种治疗方法.在EXOSC5中使用.免疫系统的透.肺部腺癌瘤是肺部腺癌.预测生物标志物 预测生物标志物瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

990
Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

341

相关概念视频

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K